# Reviewing the NVCA Management Rights Letter[^about] Review consultation, inspection, board materials, confidentiality and termination in the July 2020 NVCA model, with limited regulatory context. ## Does signing an NVCA Management Rights Letter establish venture capital operating company qualification? {#purpose-and-purchase} **Short answer.** Signing the July 2020 NVCA Management Rights Letter alone does not establish venture capital operating company (VCOC) qualification: the regulation requires investment, asset-valuation, timing and actual-exercise conditions in addition to contractual management rights. [^vcoc-direct-rights] [^vcoc-actual-exercise] The July 2020 NVCA model makes the rights effective with the identified preferred-stock purchase and adds them to rights provided to all investors in the financing. The identified investor entity, company, share number and series connect the rights to that investment. [^nvca-mrl-purchase] For the investor, the rights and their actual exercise are separate compliance questions. For the company, the selected consultation and information provisions identify the obligations it agrees to perform. This guide does not assume every fund or investment is subject to the same ERISA analysis. [Not legal advice](/disclaimer). ## When does the NVCA Management Rights Letter let an investor consult with management? {#management-consultation} **Short answer.** If the optional consultation provision is selected and the investor lacks board representation, paragraph 1 of the July 2020 NVCA Management Rights Letter provides consultation on significant business issues and regular management meetings at mutually agreeable times. [^nvca-mrl-consultation] The model includes annual operating plans and progress against those plans within the consultation. The mutually agreeable scheduling requirement operates alongside the absence-of-board-representation condition. Bracketed language is a drafting choice, not an automatic entitlement. [^nvca-mrl-consultation] ## Does the NVCA Management Rights Letter allow unrestricted records and facility inspection? {#inspection-and-information} **Short answer.** The July 2020 NVCA Management Rights Letter’s optional inspection provision permits books-and-records review, facility inspection and reasonable information requests, subject to its highly confidential proprietary information and facilities exception and reasonable times and intervals. [^nvca-mrl-inspection] For the investor, the selected inspection language defines the information available under paragraph 2; for the company, the reasonable-times-and-intervals language conditions access. [^nvca-mrl-inspection] The [separate restrictions section](#foreign-person-restrictions) addresses paragraph 4. ## Does the NVCA Management Rights Letter grant a board seat or unrestricted board access? {#board-materials} **Short answer.** When the investor lacks board representation, the July 2020 NVCA Management Rights Letter’s optional paragraph 3 provides board materials and a conditioned opportunity to address the board, rather than appointing a director, and retains good-faith, counsel-advised exclusions for privilege, highly confidential proprietary information or similar reasons. [^nvca-mrl-board-materials] [^nvca-mrl-board-address] The representative may address the board after reasonable notice at a scheduled meeting or another time the board selects; this paragraph provides a speaking opportunity rather than a director appointment. [^nvca-mrl-board-address] The [separate restrictions section](#foreign-person-restrictions) addresses paragraph 4. ## Which investor rights does the NVCA Management Rights Letter’s foreign-person provision restrict? {#foreign-person-restrictions} **Short answer.** The July 2020 NVCA Management Rights Letter’s optional paragraph 4 restricts specified control, board, technical-information and substantive-decisionmaking rights arising solely from the letter. [^nvca-mrl-restrictions] NVCA’s editorial footnote recommends counsel review before affected foreign funds choose these restrictions because of potential CFIUS/ERISA tension; it does not supply a regulatory determination for the investment. [^nvca-mrl-regulatory-tension] The bracketed carve-out excludes financial-performance information from the model’s technical-information restriction and permits consultation about that financial information. [^nvca-mrl-restrictions] Part 800 excludes financial-performance information from its definition of material nonpublic technical information; that definition does not determine every other CFIUS question. [^cfius-financial-information] NVCA’s footnotes flag tension between limiting access and retaining useful management rights. That drafting guidance identifies a need for investment-specific regulatory review; this guide does not determine CFIUS jurisdiction, a filing obligation, an exemption or VCOC qualification. [^nvca-mrl-regulatory-tension] ## Which confidentiality agreement does the NVCA Management Rights Letter incorporate? {#confidentiality} **Short answer.** Paragraph 5 of the July 2020 NVCA Management Rights Letter incorporates the confidentiality provisions of the referenced Investors’ Rights Agreement. [^nvca-mrl-confidentiality] NVCA’s editorial footnote directs the drafter to copy the confidentiality provisions into the letter if the investor is not a party to that agreement. Whether the investor is a party therefore affects how the model’s confidentiality reference is completed. [^nvca-mrl-confidentiality-note] ## When do rights under the NVCA Management Rights Letter end, and what survives? {#termination-and-execution} **Short answer.** Under paragraph 6 of the July 2020 NVCA Management Rights Letter, rights end upon loss of all investor/affiliate shareholdings, the specified public offering or a merger or consolidation satisfying the clause’s purpose conditions and any selected comparable-rights or liquid-consideration condition; confidentiality survives. [^nvca-mrl-termination] The selected merger conditions make the transaction’s terms relevant to termination. The clause distinguishes a reincorporation or wholly owned holding-company reorganization from the described terminating transaction. [^nvca-mrl-termination] The introductory agreement identifies the company, investor and purchase to which the rights attach. [^nvca-mrl-purchase-execution] The [execution checklist](/checklists/venture-financing/nvca-management-rights-letter#termination-and-execution) separately addresses completion of the signature package. Original explanation: CC BY 4.0. Quoted NVCA materials retain their original rights. [^about]: By Steven Obiajulu, J.D. Published by [openagreements.org](https://openagreements.org). Last reviewed 2026-09-16. License: CC BY 4.0. Steven Obiajulu, J.D. edits this topic article for July 2020 NVCA model; conditional VCOC and CFIUS context coverage. It synthesizes legal sources and is not legal advice. This article is for informational purposes only and does not create an attorney-client relationship. Source excerpts and linked materials belong to their owners. CC BY 4.0. Cite as Steven Obiajulu, *Reviewing the NVCA Management Rights Letter*, OpenAgreements (last updated September 16, 2026), https://openagreements.org/practice-guides/startup-financing/nvca-management-rights-letter. [^vcoc-direct-rights]: **VCOC regulation — direct management rights** — "(ii) The term ‘management rights’ means contractual rights directly between the investor and an operating company to substantially participate in, or substantially influence the conduct of, the management of the operating company." *29 C.F.R. § 2510.3-101(d)(3)(ii)* [^vcoc-actual-exercise]: **VCOC regulation — actual exercise** — "(1) An entity is a ‘venture capital operating company’ for the period beginning on an initial valuation date described in paragraph (d)(5)(i) and ending on the last day of the first ‘annual valuation period’ described in paragraph (d)(5)(ii) (in the case of an entity that is not a venture capital operating company immediately before the determination) or for the 12 month period following the expiration of an ‘annual valuation period’ described in paragraph (d)(5)(ii) (in the case of an entity that is a venture capital operating company immediately before the determination) if— (i) On such initial valuation date, or at any time within such annual valuation period, at least 50 percent of its assets (other than short-term investments pending long-term commitment or distribution to investors), valued at cost, are invested in venture capital investments described in paragraph (d)(3)(i) or derivative investments described in paragraph (d)(4); and (ii) During such 12 month period (or during the period beginning on the initial valuation date and ending on the last day of the first annual valuation period), the entity, in the ordinary course of its business, actually exercises management rights of the kind described in paragraph (d)(3)(ii) with respect to one or more of the operating companies in which it invests." *29 C.F.R. § 2510.3-101(d)(1)* [^nvca-mrl-purchase]: **NVCA Management Rights Letter — operative model text, paragraph 0** — "This letter will confirm our agreement that pursuant to and effective as of your purchase of [________] shares of Series [_] Preferred Stock of [_____________________] (the ‘Company’), [Investor Name] (the ‘Investor’) shall be entitled to the following contractual management rights, in addition to any rights to non-public financial information, inspection rights, and other rights specifically provided to all investors in the current financing:" *paragraph 0* [^nvca-mrl-consultation]: **NVCA Management Rights Letter — operative model text, paragraph 1** — "[If Investor is not represented on Company’s Board of Directors, Investor shall be entitled to consult with and advise management of the Company on significant business issues, including management’s proposed annual operating plans, and management will meet with Investor regularly during each year at the Company’s facilities at mutually agreeable times for such consultation and advice and to review progress in achieving said plans.]" *paragraph 1* [^nvca-mrl-inspection]: **NVCA Management Rights Letter — operative model text, paragraph 2** — "[Investor may examine the books and records of the Company and inspect its facilities and may request information at reasonable times and intervals concerning the general status of the Company’s financial condition and operations, provided that access to highly confidential proprietary information and facilities need not be provided.]" *paragraph 2* [^nvca-mrl-board-materials]: **NVCA Management Rights Letter — operative model text, paragraph 3** — "[If Investor is not represented on the Company’s Board of Directors, the Company shall, concurrently with delivery to the Board of Directors, give a representative of Investor copies of all notices, minutes, consents and other material that the Company provides to its directors, except that the representative may be excluded from access to any material or meeting or portion thereof if the Board of Directors determines in good faith, upon advice of counsel, that such exclusion is reasonably necessary to preserve the attorney-client privilege, to protect highly confidential proprietary information, or for other similar reasons." *paragraph 3* [^nvca-mrl-board-address]: **NVCA Management Rights Letter — operative model text, paragraph 3** — "Upon reasonable notice and at a scheduled meeting of the Board or such other time, if any, as the Board may determine in its sole discretion, such representative may address the Board with respect to Investor’s concerns regarding significant business issues facing the Company.]" *paragraph 3* [^nvca-mrl-restrictions]: **NVCA Management Rights Letter — operative model text, paragraph 4** — "[Notwithstanding anything to the contrary in this letter agreement, solely by reason of becoming party to this letter agreement, Investor will not obtain with respect to the Company, and the Company will not provide to Investor, any of the following rights, as defined in Section 721 of the Defense Production Act, as amended, including its implementing regulations: (a) ‘control’ of the Company, including the power to determine, direct or decide any important matters affecting the Company; (b) membership or observer rights on the Board of Directors or equivalent body of the Company, or the right to nominate an individual to a position on the Board of Directors or equivalent body of the Company; (c) access to any ‘material nonpublic technical information’ in the possession of the Company [(provided, however, that such prohibited information shall not include financial information regarding the performance of the Company, and provided further that Investor may confer with the Company about such financial information)]; and (d) any ‘involvement’ (other than through voting of shares) in ‘substantive decision making’ of the Company regarding (i) the use, development, acquisition, safekeeping, or release of ‘sensitive personal data’ of U.S. citizens maintained or collected by the Company, (ii) the use, development, acquisition, or release of ‘critical technologies,’ or (iii) the management, operation, manufacture, or supply of ‘covered investment critical infrastructure.’" *paragraph 4* [^nvca-mrl-regulatory-tension]: **NVCA Management Rights Letter — editorial footnote 4** — "Because of the inherent tension between the CFIUS and ERISA regimes in this context, Foreign funds with known ERISA concerns should consult counsel before deciding what language to include and exclude in this agreement." *NVCA Management Rights Letter (July 2020), footnote 4.* [^cfius-financial-information]: **CFIUS regulation — financial information** — "(b) The term material nonpublic technical information does not include financial information regarding the performance of an entity." *31 C.F.R. § 800.232(b)* [^nvca-mrl-confidentiality]: **NVCA Management Rights Letter — operative model text, paragraph 5** — "Investor agrees that any confidential information provided to or learned by it in connection with its rights under this letter shall be subject to the confidentiality provisions set forth in that certain Investors’ Rights Agreement of even date herewith by and among the Company, the Investor and other investors." *paragraph 5* [^nvca-mrl-confidentiality-note]: **NVCA Management Rights Letter — editorial footnote 5** — "If for some reason the Investor is not a party to the Investors’ Rights Agreement, you will need to copy the confidentiality provisions from the Investors’ Rights Agreement here." *footnote 5* [^nvca-mrl-termination]: **NVCA Management Rights Letter — operative model text, paragraph 6** — "The rights described herein shall terminate and be of no further force or effect upon (a) such time as no shares of the Company’s stock are held by the Investor or its affiliates; (b) the consummation of the sale of the Company’s securities pursuant to a registration statement filed by the Company under the Securities Act of 1933, as amended, in connection with the firm commitment underwritten offering of its securities to the general public; or (c) the consummation of a merger or consolidation of the Company [(x)] that is effected (i) for independent business reasons unrelated to extinguishing such rights; and (ii) for purposes other than (A) the reincorporation of the Company in a different state; or (B) the formation of a holding company that will be owned exclusively by the Company’s stockholders and will hold all of the outstanding shares of capital stock of the Company’s successor and [(y) in which the successor entity provides reasonably comparable rights to the Investor or the consideration payable to the Investor in such transaction consists solely of cash or securities of a class listed on a national exchange]. The confidentiality obligations referenced herein will survive any such termination." *paragraph 6* [^nvca-mrl-purchase-execution]: **NVCA Management Rights Letter — operative model text, paragraph 0** — "This letter will confirm our agreement that pursuant to and effective as of your purchase of [________] shares of Series [_] Preferred Stock of [_____________________] (the ‘Company’), [Investor Name] (the ‘Investor’) shall be entitled to the following contractual management rights, in addition to any rights to non-public financial information, inspection rights, and other rights specifically provided to all investors in the current financing:" *paragraph 0* For repeat use, install the skill: `npx skills add open-agreements/open-agreements` (lawyer-reviewed agreement templates + 50-state practice guides).